Aurinia Pharmaceuticals Inc (AUPH)
Stock-Based Compensation
$2.84M
Quarterly · Period ending: · USD
AUPH Stock-Based Compensation
Latest reported$2.84Mperiod ending
Latest reported$2.84Mperiod ending
AUPH Quarterly Stock-Based Comp ($0.00 → $2.84M)
Quarterly stock-based compensation
High-resolution chart · PNG
AUPH stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 2,839,000 | |
| -866,000 | |
| 0 | |
| 5,919,000 | |
| 5,440,000 | |
| -3,409,000 | |
| 8,946,000 | |
| 8,327,000 | |
| 8,586,000 | |
| 5,737,000 | |
| 11,768,000 | |
| 11,808,000 | |
| 12,268,000 | |
| 9,467,000 | |
| 6,902,000 | |
| 8,320,000 | |
| 10,055,000 | |
| 7,023,000 | |
| 8,577,000 | |
| 7,092,000 | |
| 7,753,000 | |
| 7,821,000 | |
| 5,145,000 | |
| 4,611,000 | |
| 4,202,000 | |
| 3,496,000 | |
| 1,828,000 | |
| 2,022,000 | |
| 1,960,000 | |
| 1,604,000 | |
| 1,214,000 | |
| 1,506,000 | |
| 2,029,000 | |
| 2,111,000 | |
| 955,000 | |
| 1,068,000 | |
| 978,000 | |
| 1,241,000 | |
| 356,000 | |
| 548,000 | |
| 150,000 | |
| 329,000 | |
| 488,000 | |
| 679,000 | |
| 773,000 | |
| 1,284,000 | |
| 167,000 | |
| 286,000 | |
| 435,000 | |
| 1,298,000 | |
| 13,165 | |
| 29,081 | |
| 76,984 | |
| 104,182 | |
| 148,412 | |
| 38,608 | |
| 36,377 | |
| 51,117 | |
| 137,996 | |
| 210,492 | |
| 12,426 | |
| 10,289 | |
| 0 | |
| 133,935 | |
| 92,239 | |
| 51,010 | |
| 0 | |
| 0 | |
| 39,316 | |
| 6,336 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |